# Outcomes of Stem Cells for Cerebral Palsy

> **NCT02574923** · PHASE2 · COMPLETED · sponsor: **Vinmec Healthcare System** · enrollment: 30 (actual)

## Conditions studied

- Cerebral Palsy

## Interventions

- **BIOLOGICAL:** Autologous Bone Marrow Mononuclear Cells

## Key facts

- **NCT ID:** NCT02574923
- **Lead sponsor:** Vinmec Healthcare System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-05
- **Primary completion:** 2018-03-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02574923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02574923, "Outcomes of Stem Cells for Cerebral Palsy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02574923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*